Stock Scorecard
Stock Summary for Abbvie Inc (ABBV) - $166.57 as of 11/20/2024 7:40:14 PM EST
Total Score
9 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ABBV
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ABBV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ABBV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ABBV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ABBV (66 out of 90)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 8 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 2 |
Latest News for for ABBV
Financial Details for ABBV
Company Overview |
|
|---|---|
| Ticker | ABBV |
| Company Name | Abbvie Inc |
| Country | USA |
| Description | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 1/31/2025 |
Stock Price History |
|
| Last Day Price | 166.57 |
| Price 4 Years Ago | 91.21 |
| Last Day Price Updated | 11/20/2024 7:40:14 PM EST |
| Last Day Volume | 5,245,994 |
| Average Daily Volume | 6,424,200 |
| 52-Week High | 207.32 |
| 52-Week Low | 132.79 |
| Last Price to 52 Week Low | 25.44% |
Valuation Measures |
|
| Trailing PE | 58.04 |
| Industry PE | 22.60 |
| Sector PE | 40.32 |
| 5-Year Average PE | 13.41 |
| Free Cash Flow Ratio | 40.43 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 0.65 |
| Total Cash Per Share | 4.12 |
| Book Value Per Share Most Recent Quarter | 3.41 |
| Price to Book Ratio | 48.80 |
| Industry Price to Book Ratio | 5.31 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 5.30 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 9 |
Share Statistics |
|
| Total Shares Outstanding | 1,767,140,000 |
| Market Capitalization | 294,352,509,800 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 1/15/2025 |
| Last Dividend Amount | 1.55 |
| Current Dividend Amount | 1.64 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 7.84 |
| Trailing Annual Dividend Yield | 4.71% |
| Forward Annual Dividend Rate | 8.50 |
| Forward Annual Dividend Yield | 5.10% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 3.72% |
| 5-Year Average Dividend Yield | 4.08% |
| 1-Year Dividend Growth Rate Percentage | 4.96% |
| 3-Year Dividend Growth Rate Percentage | 6.70% |
| 5-Year Dividend Growth Rate Percentage | 8.45% |
| All-Time Dividend Growth Rate Percentage | 13.98% |
| Dividend Payout Ratio | 273.17% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -12.30% |
| Annual Earnings Growth | -58.91% |
| Reported EPS 12 Trailing Months | 2.87 |
| Reported EPS Past Year | 7.96 |
| Reported EPS Prior Year | 11.11 |
| Net Income Twelve Trailing Months | 5,122,000,000 |
| Net Income Past Year | 4,863,000,000 |
| Net Income Prior Year | 11,836,000,000 |
| Quarterly Revenue Growth YOY | 3.80% |
| 5-Year Revenue Growth | 10.65% |
| Operating Margin Twelve Trailing Months | 0.29 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 7,285,000,000 |
| Total Cash Past Year | 12,816,000,000 |
| Total Cash Prior Year | 9,229,000,000 |
| Net Cash Position Most Recent Quarter | -50,763,000,000 |
| Net Cash Position Past Year | -46,429,000,000 |
| Long Term Debt Past Year | 59,245,000,000 |
| Long Term Debt Prior Year | 63,128,000,000 |
| Total Debt Most Recent Quarter | 58,048,000,000 |
| Equity to Debt Ratio Past Year | 0.15 |
| Equity to Debt Ratio Most Recent Quarter | 0.09 |
| Total Stockholder Equity Past Year | 10,360,000,000 |
| Total Stockholder Equity Prior Year | 17,254,000,000 |
| Total Stockholder Equity Most Recent Quarter | 6,032,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 15,623,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 8.84 |
| Free Cash Flow Past Year | 22,062,000,000 |
| Free Cash Flow Prior Year | 24,248,000,000 |
Options |
|
| Put/Call Ratio | 1.86 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -5.72 |
| MACD Signal | -2.05 |
| 20-Day Bollinger Lower Band | 165.66 |
| 20-Day Bollinger Middle Band | 187.36 |
| 20-Day Bollinger Upper Band | 209.06 |
| Beta | 0.61 |
| RSI | 26.00 |
| 50-Day SMA | 172.32 |
| 150-Day SMA | 149.26 |
| 200-Day SMA | 136.85 |
System |
|
| Modified | 11/20/2024 4:18:27 PM EST |